241 related articles for article (PubMed ID: 20522599)
21. Effect of the monocyte chemoattractant protein-1/CC chemokine receptor 2 system on nephrin expression in streptozotocin-treated mice and human cultured podocytes.
Tarabra E; Giunti S; Barutta F; Salvidio G; Burt D; Deferrari G; Gambino R; Vergola D; Pinach S; Perin PC; Camussi G; Gruden G
Diabetes; 2009 Sep; 58(9):2109-18. PubMed ID: 19587356
[TBL] [Abstract][Full Text] [Related]
22. Mesenchymal stem cells ameliorate podocyte injury and proteinuria in a type 1 diabetic nephropathy rat model.
Wang S; Li Y; Zhao J; Zhang J; Huang Y
Biol Blood Marrow Transplant; 2013 Apr; 19(4):538-46. PubMed ID: 23295166
[TBL] [Abstract][Full Text] [Related]
23. Tongluo Digui decoction treats renal injury in diabetic rats by promoting autophagy of podocytes.
Han J; Zhang Y; Shi X; Peng Z; Xing Y; Pang X
J Tradit Chin Med; 2021 Feb; 41(1):125-132. PubMed ID: 33522205
[TBL] [Abstract][Full Text] [Related]
24. [Correlation between expressions of VEGF and TRPC6 and their roles in podocyte injury in rats with diabetic nephropathy].
Zhu XN; Wang YH; Wu JJ; Dong P; Zhang M
Nan Fang Yi Ke Da Xue Xue Bao; 2018 Mar; 38(3):296-304. PubMed ID: 29643035
[TBL] [Abstract][Full Text] [Related]
25. Perilipin2 inhibits diabetic nephropathy-induced podocyte apoptosis by activating the PPARγ signaling pathway.
Dai ZW; Cai KD; Xu LC; Wang LL
Mol Cell Probes; 2020 Oct; 53():101584. PubMed ID: 32387304
[TBL] [Abstract][Full Text] [Related]
26. Selective phosphodiesterase-5 (PDE-5) inhibitor vardenafil ameliorates renal damage in type 1 diabetic rats by restoring cyclic 3',5' guanosine monophosphate (cGMP) level in podocytes.
Fang L; Radovits T; Szabó G; Mózes MM; Rosivall L; Kökény G
Nephrol Dial Transplant; 2013 Jul; 28(7):1751-61. PubMed ID: 23203993
[TBL] [Abstract][Full Text] [Related]
27. Valsartan ameliorates podocyte loss in diabetic mice through the Notch pathway.
Gao F; Yao M; Cao Y; Liu S; Liu Q; Duan H
Int J Mol Med; 2016 May; 37(5):1328-36. PubMed ID: 26985716
[TBL] [Abstract][Full Text] [Related]
28. TMEM16A exacerbates renal injury by activating P38/JNK signaling pathway to promote podocyte apoptosis in diabetic nephropathy mice.
Lian H; Cheng Y; Wu X
Biochem Biophys Res Commun; 2017 May; 487(2):201-208. PubMed ID: 28392397
[TBL] [Abstract][Full Text] [Related]
29. Knockdown of TLR4 attenuates high glucose-induced podocyte injury via the NALP3/ASC/Caspase-1 signaling pathway.
Liu Y; Xu Z; Ma F; Jia Y; Wang G
Biomed Pharmacother; 2018 Nov; 107():1393-1401. PubMed ID: 30257355
[TBL] [Abstract][Full Text] [Related]
30. [Triptolide inhibits NLRP3 inflammasome activation and ameliorates podocyte epithelial-mesenchymal transition induced by high glucose].
Wu W; Liu BH; Wan YG; Sun W; Liu YL; Wang WW; Fang QJ; Tu Y; Yee HY; Yuan CC; Wan ZY
Zhongguo Zhong Yao Za Zhi; 2019 Dec; 44(24):5457-5464. PubMed ID: 32237395
[TBL] [Abstract][Full Text] [Related]
31. MDM2 is implicated in high-glucose-induced podocyte mitotic catastrophe via Notch1 signalling.
Tang H; Lei CT; Ye C; Gao P; Wan C; Chen S; He FF; Wang YM; Su H; Zhang C
J Cell Mol Med; 2017 Dec; 21(12):3435-3444. PubMed ID: 28643424
[TBL] [Abstract][Full Text] [Related]
32. Absence of miR-146a in Podocytes Increases Risk of Diabetic Glomerulopathy via Up-regulation of ErbB4 and Notch-1.
Lee HW; Khan SQ; Khaliqdina S; Altintas MM; Grahammer F; Zhao JL; Koh KH; Tardi NJ; Faridi MH; Geraghty T; Cimbaluk DJ; Susztak K; Moita LF; Baltimore D; Tharaux PL; Huber TB; Kretzler M; Bitzer M; Reiser J; Gupta V
J Biol Chem; 2017 Jan; 292(2):732-747. PubMed ID: 27913625
[TBL] [Abstract][Full Text] [Related]
33. Notch pathway is involved in high glucose-induced apoptosis in podocytes via Bcl-2 and p53 pathways.
Gao F; Yao M; Shi Y; Hao J; Ren Y; Liu Q; Wang X; Duan H
J Cell Biochem; 2013 May; 114(5):1029-38. PubMed ID: 23129176
[TBL] [Abstract][Full Text] [Related]
34. VEGF and podocytes in diabetic nephropathy.
Tufro A; Veron D
Semin Nephrol; 2012 Jul; 32(4):385-93. PubMed ID: 22958493
[TBL] [Abstract][Full Text] [Related]
35. Increased SHP-1 protein expression by high glucose levels reduces nephrin phosphorylation in podocytes.
Denhez B; Lizotte F; Guimond MO; Jones N; Takano T; Geraldes P
J Biol Chem; 2015 Jan; 290(1):350-8. PubMed ID: 25404734
[TBL] [Abstract][Full Text] [Related]
36. Sulfiredoxin-1 alleviates high glucose-induced podocyte injury though promoting Nrf2/ARE signaling via inactivation of GSK-3β.
Shen Y; Chen S; Zhao Y
Biochem Biophys Res Commun; 2019 Sep; 516(4):1137-1144. PubMed ID: 31284950
[TBL] [Abstract][Full Text] [Related]
37. [The effects of VEGF-R inhibitor on podocytopathy of rats with type I diabetic nephropathy].
Wang S; Li Y; Huang YJ
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Sep; 27(9):1003-6. PubMed ID: 21906476
[TBL] [Abstract][Full Text] [Related]
38. Autocrine VEGF-A system in podocytes regulates podocin and its interaction with CD2AP.
Guan F; Villegas G; Teichman J; Mundel P; Tufro A
Am J Physiol Renal Physiol; 2006 Aug; 291(2):F422-8. PubMed ID: 16597608
[TBL] [Abstract][Full Text] [Related]
39. Prolonged exposure of mouse and human podocytes to insulin induces insulin resistance through lysosomal and proteasomal degradation of the insulin receptor.
Lay AC; Hurcombe JA; Betin VMS; Barrington F; Rollason R; Ni L; Gillam L; Pearson GME; Østergaard MV; Hamidi H; Lennon R; Welsh GI; Coward RJM
Diabetologia; 2017 Nov; 60(11):2299-2311. PubMed ID: 28852804
[TBL] [Abstract][Full Text] [Related]
40. Sirt6 deficiency exacerbates podocyte injury and proteinuria through targeting Notch signaling.
Liu M; Liang K; Zhen J; Zhou M; Wang X; Wang Z; Wei X; Zhang Y; Sun Y; Zhou Z; Su H; Zhang C; Li N; Gao C; Peng J; Yi F
Nat Commun; 2017 Sep; 8(1):413. PubMed ID: 28871079
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
